A State-of-the-Art review published in JACC: Cardiovascular Interventions covers the epidemiology, clinical implications, risk factors and preventive strategies for new-onset conduction disturbances ...
In this week’s View, Dr. Eagle looks at the 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. He then discusses sex differences in ...
Registration is now open for May's Certified Cardiovascular Knowledge (CCK) Exam for NPs/PAs. Designed for NPs/PAs practicing in the U.S., the online exam's 150 questions will test the depth of your ...
Time is running out to showcase your expertise! JACC: Case Reports is seeking standout cases that highlight the critical role of multi-modality imaging in the diagnosis or intervention of complex ...
What an amazing year 2024 was in terms of advances in cardiovascular care! With more than 882,000 users, ACC.org continues to be a critical resource for cardiovascular clinicians around the world! The ...
The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...
Multimodality imaging can identify papillary muscles that are the source of arrhythmias. Increased echogenicity, gadolinium enhancement, and calcifications on papillary muscles can indicate site of ...
Early increases in CRP during immune checkpoint inhibitor (ICI) therapy are linked to a higher risk of venous thromboembolism (VTE). CRP trajectories could serve as biomarkers for assessing VTE risk ...
The Centers for Medicare and Medicaid Services (CMS) created two new G codes in the 2025 Medicare Physician Fee Schedule final rule that will provide reimbursement for atherosclerotic cardiovascular ...
The following are key points to remember from a state-of-the-art review on cardiovascular (CV) risk in prostate cancer (PC): ...
Chlorthalidone is not superior to hydrochlorothiazide in preventing kidney disease progression in patients with hypertension. Chlorthalidone causes slightly more hypokalemia than hydrochlorothiazide.